Juniper Biomedical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Juniper Biomedical - overview
Established
2019
Location
Worcester, MA, US
Primary Industry
Medical Devices & Equipment
About
Based in Massachusetts, US, and founded in 2019 by co-founders David N. Constantine (CEO) and Mario Romero-Ortega, PhD, Juniper Biomedical operates as a pelvic health provider that offers precise neuromodulation therapy to treat pelvic floor disorders, including overactive bladder. In April 2024, Juniper Biomedical raised USD 2 million in seed funding led by Auroral Holdings, with participation from Atma Capital, Hub Angels, and Beacon Angels. The company offers a battery-powered micro-implant solution that is placed into the pelvic floor and uses precision neuromodulation technology to treat a range of pelvic health conditions, including pelvic pain, sexual dysfunction, urine and bowel incontinence, and other pelvic health conditions.
Current Investors
Hub Angels Investment Group, Beacon Angels, Atma Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.juniperbiomedical.com/
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.